Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05916287

FAMILY INHERITANCE, GENE-GENE AND GENE-ENVIRONMENT INTERACTIONS IN THE FIELD OF CARDIOVASCULAR AND RENAL DISEASES. Fifth Visit of the STANISLAS Cohort

HÉRITABILITÉ FAMILIALE, INTERACTIONS GÈNE-GÈNE ET GÈNE-ENVIRONNEMENT DANS LE DOMAINE DES MALADIES CARDIOVASCULAIRES ET RENALES. Cinquième Visite de la Cohorte STANISLAS

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
3,000 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The Stanislas Cohort is a monocentric familial longitudinal cohort originally comprised of 1006 families consisting of two parents and at least two biological children and deemed healthy, recruited in 1993-1995 at the Centre for Preventive Medicine of Nancy. This cohort was established with the primary objective of investigating gene-gene and gene-environment interactions in the field of cardiovascular diseases. The 5th visit of the STANISLAS Cohort will allow a better evaluation of the cardiovascular ageing of the population and the transition toward cardiovascular or renal diseases in relation with their genetic profile and environment.

Detailed description

The main objective of the STANISLAS cohort is to identify the factors associated with cardiovascular aging (assessed through the study of the degradation of morphological and functional parameters of the heart and vascular systems). Data (clinical, biological, morphological, genetic and lifestyle) from previous visits (the first having been initiated in the mid-1990s) will be considered as exposure and / or adjustment variables. The exposure variables of interest will be: * The components of metabolic syndrome (MS), * Genetic determinants, through an approach of family segregation and candidate genes, * Multi-omic biomarkers analyzed from the biological collection of the first assessments of the cohort * Food intake, nutrition and eating behavior The secondary objectives are * Identify the factors associated with a degradation of renal parameters (renal function and proteinuria). * Identify the factors associated with a degradation of metabolic parameters. * To assess the association between SARS-CoV-2 infection (questionnaire and serological approach) and cardiovascular and renal parameters * Identify factors associated with the occurrence of clinical cardiovascular events. * Association between Covid 19 events and general disabling symptoms * Complete the cohort's biological collection for future biomarker assays related to previous objectives

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood and urine samplesBlood and urine samples
GENETICBlood samplesBlood samples
OTHERCardiovascular assessmentEchocardiography, Lung ultrasound, pulse wave velocity, carotid stiffness and thickness, Central and peripheral blood pressure, carotid pulse pressure, abdominal aorta ultrasound, jugular vein ultrasound, liver elastography (Optional).
BEHAVIORALDietary intakeFood frequency questionnaires, ''Dutch eating behaviour questionnaire'' and dietary supplement questionnaire
OTHERAnthropometric parametersMeasurement of height, weight, abdominal circumference, hip circumference, arm circumference
OTHERHemodynamic parametersSystolic pressure index measurement
OTHERHemodynamic parametersHeart rate measurements, blood pressure measurements, orthostatic BP measurements
OTHERHemodynamic parametersBlood pressure measurements by "unattended BP" monitor over 5 min
OTHERHemodynamic parametersElectrocardiogram
BEHAVIORALAssessment of compliance with antihypertensive treatments for treated participantsEVALOBS scale and compliance questionnaire
OTHERAmbulatory 24 hours measurment of blood pressureFor the first 100 patients willing to participate
BIOLOGICAL24 hours urinary collectionFor the first 100 patients willing to participate. For biobank constitution and measurement of microalbuminuria, creatininuria, osmolarity, natriuresis, kaliuresis, urea, proteinuria and urine dipstick
OTHERGeneral questionnairesCollection of socio-demographic data such as age, level of education, profession, household income, smoking status, physical activity, perception of health, prematurity, height and weight at birth, family and personal history especially cardiovascular (history of stroke, myocardial infarction, heart failure, current pathologies, drugs, tobacco...)
OTHERWomen specific questionnaireWomen specific questionnaire
BEHAVIORALWomen specific questionnaireWomen specific questionnaire
DIAGNOSTIC_TESTNYHA dyspnea questionnaireDetermination of NYHA class.
BEHAVIORALAnxiety questionnaireAssessment of anxiety
BEHAVIORALEpworth Sleepiness Scalesleep quality assessment
OTHERA questionnaire on the "perception of the management of cardiovascular risk factors"Patient's evaluation of cardiovascular risk factors by the health system
BEHAVIORALA questionnaire on eating behaviorsAssessment of eating behaviors
BEHAVIORALA questionnaire on eating habits to determine consumer profilesAssessement of eating habit to create a consumer profile
DIETARY_SUPPLEMENTA questionnaire on food supplements useEvaluation od food supplements intake
OTHERSARS-CoV-2 Infection QuestionnaireSARS-CoV-2 Infection Questionnaire
OTHERInstantaneous expired air analysisCarbon monoxyde analysis in expired air
BIOLOGICALCapillary samplingCapillary sampling for pollutant analysis (Optional)

Timeline

Start date
2023-07-13
Primary completion
2027-07-13
Completion
2027-07-13
First posted
2023-06-23
Last updated
2023-08-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05916287. Inclusion in this directory is not an endorsement.